Drug Profile
Fedotozine
Alternative Names: JO 1196Latest Information Update: 14 Jun 2001
Price :
$50
*
At a glance
- Originator Jouveinal
- Class Benzyl compounds; Gastrokinetics; Propylamines; Small molecules
- Mechanism of Action Opioid kappa receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Irritable bowel syndrome; Non-ulcer dyspepsia
Most Recent Events
- 14 Jun 2001 No-Development-Reported for Irritable bowel syndrome in Australia (PO)
- 14 Jun 2001 No-Development-Reported for Irritable bowel syndrome in Canada (PO)
- 14 Jun 2001 No-Development-Reported for Irritable bowel syndrome in France (PO)